Synthetische Antiproliferativer Faktor Glykopeptiden und Anwendungsverfahren
Anmelder: University of Maryland, Baltimore, The United States of America, as represented by The Secretary, Department of Health and Human Services, The United States of America, as represented by the Department of Veterans Affairs, Government of the United States of America as represented by The Secretary of the Department of Health and Human Services, The Government of the United States of America, represented by the Secretary, Department of Health and Human Services 🇺🇸
Details
- Veröffentlichungs-Nr.
- EP1648492
- Aktenzeichen
- EP04777402
- Anmeldetag
- 1. Juli 2004
- Veröffentlichung
- 11. Dezember 2013
- Erteilung
- 11. Dezember 2013
- Rechtsraum
- EP
- IPC
- A61K38/08A61P35/00
Abstract
Für dieses Patent liegt uns kein Abstract vor.
Anmelder
- Firmen
- University of Maryland, Baltimore
The United States of America, as represented by The Secretary, Department of Health and Human Services
The United States of America, as represented by the Department of Veterans Affairs
Government of the United States of America as represented by The Secretary of the Department of Health and Human Services
The Government of the United States of America, represented by the Secretary, Department of Health and Human Services - Land
- 🇺🇸 USA
US-amerikanische Universität mit medizinischem und pharmazeutischem Schwerpunkt in Maryland. Patente entstehen vor allem in der biomedizinischen und pharmazeutischen Forschung.
489 Patente in unserer Datenbank
US-Bundesministerium, das über seine Behörden (u.a. NIH) medizinische Forschung fördert und daraus resultierende Patente im Namen der US-Regierung hält.
391 Patente in unserer Datenbank